nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—prostate cancer	0.211	0.889	CbGaD
Equilin—Estrone—prostate cancer	0.106	0.296	CrCtD
Equilin—Conjugated Estrogens—prostate cancer	0.0933	0.261	CrCtD
Equilin—Estradiol—prostate cancer	0.0803	0.224	CrCtD
Equilin—Ethinyl Estradiol—prostate cancer	0.0784	0.219	CrCtD
Equilin—SHBG—Estrone—prostate cancer	0.0538	0.406	CbGbCtD
Equilin—SHBG—Ethinyl Estradiol—prostate cancer	0.0479	0.361	CbGbCtD
Equilin—SHBG—Estradiol—prostate cancer	0.0309	0.233	CbGbCtD
Equilin—SHBG—prostate cancer	0.0264	0.111	CbGaD
Equilin—Estriol—Estramustine—prostate cancer	0.0128	0.0534	CrCrCtD
Equilin—Dezocine—Estrone—prostate cancer	0.0112	0.0466	CrCrCtD
Equilin—Estropipate—Estramustine—prostate cancer	0.0109	0.0455	CrCrCtD
Equilin—Conjugated Estrogens—Estramustine—prostate cancer	0.0109	0.0455	CrCrCtD
Equilin—Estriol—Estrone—prostate cancer	0.0102	0.0424	CrCrCtD
Equilin—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00948	0.0396	CrCrCtD
Equilin—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.00948	0.0396	CrCrCtD
Equilin—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00903	0.0378	CrCrCtD
Equilin—Estriol—Conjugated Estrogens—prostate cancer	0.00894	0.0374	CrCrCtD
Equilin—Conjugated Estrogens—Estrone—prostate cancer	0.00865	0.0361	CrCrCtD
Equilin—Estropipate—Estrone—prostate cancer	0.00865	0.0361	CrCrCtD
Equilin—Dezocine—Estradiol—prostate cancer	0.00845	0.0353	CrCrCtD
Equilin—Estrone—Estramustine—prostate cancer	0.00806	0.0337	CrCrCtD
Equilin—Estradiol—Estramustine—prostate cancer	0.00806	0.0337	CrCrCtD
Equilin—Estriol—Estradiol—prostate cancer	0.00769	0.0322	CrCrCtD
Equilin—Ethinyl Estradiol—Estramustine—prostate cancer	0.00768	0.0321	CrCrCtD
Equilin—Estropipate—Conjugated Estrogens—prostate cancer	0.00761	0.0318	CrCrCtD
Equilin—Estriol—Ethinyl Estradiol—prostate cancer	0.00751	0.0314	CrCrCtD
Equilin—Estropipate—Estradiol—prostate cancer	0.00655	0.0274	CrCrCtD
Equilin—Conjugated Estrogens—Estradiol—prostate cancer	0.00655	0.0274	CrCrCtD
Equilin—Estradiol—Estrone—prostate cancer	0.00641	0.0268	CrCrCtD
Equilin—Estropipate—Ethinyl Estradiol—prostate cancer	0.00639	0.0267	CrCrCtD
Equilin—Conjugated Estrogens—Ethinyl Estradiol—prostate cancer	0.00639	0.0267	CrCrCtD
Equilin—Ethinyl Estradiol—Estrone—prostate cancer	0.0061	0.0255	CrCrCtD
Equilin—Estrone—Conjugated Estrogens—prostate cancer	0.00564	0.0236	CrCrCtD
Equilin—Estradiol—Conjugated Estrogens—prostate cancer	0.00564	0.0236	CrCrCtD
Equilin—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.00537	0.0225	CrCrCtD
Equilin—Estrone—Estradiol—prostate cancer	0.00485	0.0203	CrCrCtD
Equilin—Estrone—Ethinyl Estradiol—prostate cancer	0.00474	0.0198	CrCrCtD
Equilin—Estradiol—Ethinyl Estradiol—prostate cancer	0.00474	0.0198	CrCrCtD
Equilin—Ethinyl Estradiol—Estradiol—prostate cancer	0.00463	0.0193	CrCrCtD
Equilin—SHBG—semen—prostate cancer	0.00138	0.671	CbGeAlD
Equilin—SHBG—prostate gland—prostate cancer	0.000347	0.168	CbGeAlD
Equilin—SHBG—bone marrow—prostate cancer	0.000179	0.0867	CbGeAlD
Equilin—SHBG—testis—prostate cancer	0.000153	0.0741	CbGeAlD
Equilin—Ethinyl Estradiol—AOX1—prostate cancer	0.000123	0.0828	CrCbGaD
Equilin—Estriol—ESR2—prostate cancer	9.16e-05	0.0615	CrCbGaD
Equilin—Estriol—SHBG—prostate cancer	8.35e-05	0.0561	CrCbGaD
Equilin—Estradiol—AOX1—prostate cancer	8.14e-05	0.0547	CrCbGaD
Equilin—Estropipate—ESR2—prostate cancer	7e-05	0.047	CrCbGaD
Equilin—Estropipate—SHBG—prostate cancer	6.39e-05	0.0429	CrCbGaD
Equilin—Estropipate—SLC22A1—prostate cancer	6.3e-05	0.0424	CrCbGaD
Equilin—Estriol—ESR1—prostate cancer	5.64e-05	0.0379	CrCbGaD
Equilin—Ethinyl Estradiol—ESR2—prostate cancer	5e-05	0.0336	CrCbGaD
Equilin—Conjugated Estrogens—COMT—prostate cancer	4.69e-05	0.0315	CrCbGaD
Equilin—Ethinyl Estradiol—SHBG—prostate cancer	4.56e-05	0.0307	CrCbGaD
Equilin—Conjugated Estrogens—ESR2—prostate cancer	4.37e-05	0.0294	CrCbGaD
Equilin—Estrone—ESR2—prostate cancer	4.36e-05	0.0293	CrCbGaD
Equilin—Estropipate—ESR1—prostate cancer	4.31e-05	0.029	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	4.24e-05	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SULT1E1—prostate cancer	4.22e-05	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SRD5A1—prostate cancer	4.22e-05	0.00144	CbGpPWpGaD
Equilin—Estradiol—SLC22A3—prostate cancer	4.15e-05	0.0279	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—GRPR—prostate cancer	4.1e-05	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	4.1e-05	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.04e-05	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACSL4—prostate cancer	4.03e-05	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD17B3—prostate cancer	4.03e-05	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	3.98e-05	0.00136	CbGpPWpGaD
Equilin—Estrone—CYP1B1—prostate cancer	3.98e-05	0.0267	CrCbGaD
Equilin—Estrone—SHBG—prostate cancer	3.98e-05	0.0267	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—IL17RD—prostate cancer	3.96e-05	0.00136	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ARG2—prostate cancer	3.86e-05	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PHGDH—prostate cancer	3.86e-05	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—UMPS—prostate cancer	3.86e-05	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	3.84e-05	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LDHB—prostate cancer	3.79e-05	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP3A5—prostate cancer	3.72e-05	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Disease—GSTO1—prostate cancer	3.65e-05	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PDHA1—prostate cancer	3.59e-05	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA3—prostate cancer	3.59e-05	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—UCP3—prostate cancer	3.59e-05	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TCN2—prostate cancer	3.59e-05	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUP—prostate cancer	3.53e-05	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—WNT4—prostate cancer	3.53e-05	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Disease—LRP2—prostate cancer	3.5e-05	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Disease—EIF2AK2—prostate cancer	3.43e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Disease—P4HB—prostate cancer	3.43e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Disease—RPL10—prostate cancer	3.43e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC22A3—prostate cancer	3.43e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD3B1—prostate cancer	3.43e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RALBP1—prostate cancer	3.37e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MC2R—prostate cancer	3.37e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIST1H2BG—prostate cancer	3.37e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.32e-05	0.00114	CbGpPWpGaD
Equilin—Estradiol—ESR2—prostate cancer	3.3e-05	0.0222	CrCbGaD
Equilin—HSD17B1—Metabolism—TBXAS1—prostate cancer	3.29e-05	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA4—prostate cancer	3.29e-05	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIST1H4H—prostate cancer	3.25e-05	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Disease—NPPA—prostate cancer	3.25e-05	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.21e-05	0.0011	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA2—prostate cancer	3.2e-05	0.00109	CbGpPWpGaD
Equilin—Estrone—CYP3A5—prostate cancer	3.17e-05	0.0213	CrCbGaD
Equilin—HSD17B1—Metabolism—SULT1A1—prostate cancer	3.16e-05	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCG5—prostate cancer	3.16e-05	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA1—prostate cancer	3.09e-05	0.00106	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—prostate cancer	3.08e-05	0.0207	CrCbGaD
Equilin—HSD17B1—Metabolism—GSTO1—prostate cancer	3.05e-05	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NAT2—prostate cancer	3.05e-05	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD3B2—prostate cancer	3.05e-05	0.00104	CbGpPWpGaD
Equilin—Estradiol—SHBG—prostate cancer	3.01e-05	0.0202	CrCbGaD
Equilin—Estradiol—CYP1B1—prostate cancer	3.01e-05	0.0202	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PENK—prostate cancer	3e-05	0.00103	CbGpPWpGaD
Equilin—Estradiol—SLC22A1—prostate cancer	2.97e-05	0.02	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.94e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLCB2—prostate cancer	2.93e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2C18—prostate cancer	2.93e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LRP2—prostate cancer	2.93e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—P4HB—prostate cancer	2.87e-05	0.000982	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GHR—prostate cancer	2.87e-05	0.00098	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC22A1—prostate cancer	2.79e-05	0.000955	CbGpPWpGaD
Equilin—HSD17B1—Disease—B2M—prostate cancer	2.76e-05	0.000945	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFBR1—prostate cancer	2.76e-05	0.000945	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.76e-05	0.000944	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRP1—prostate cancer	2.75e-05	0.000939	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SULT2A1—prostate cancer	2.72e-05	0.000931	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1C3—prostate cancer	2.72e-05	0.00093	CbGpPWpGaD
Equilin—HSD17B1—Disease—RPS19—prostate cancer	2.72e-05	0.00093	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKACB—prostate cancer	2.7e-05	0.000925	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—prostate cancer	2.69e-05	0.0181	CrCbGaD
Equilin—Estrone—ESR1—prostate cancer	2.69e-05	0.018	CrCbGaD
Equilin—HSD17B1—Metabolism—MED12—prostate cancer	2.68e-05	0.000916	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNG5—prostate cancer	2.66e-05	0.000909	CbGpPWpGaD
Equilin—Estradiol—AR—prostate cancer	2.64e-05	0.0177	CrCbGaD
Equilin—HSD17B1—Disease—PPP3CA—prostate cancer	2.64e-05	0.000902	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA3—prostate cancer	2.56e-05	0.000875	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VIP—prostate cancer	2.55e-05	0.000873	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNRH1—prostate cancer	2.55e-05	0.000873	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCZ—prostate cancer	2.55e-05	0.000872	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.51e-05	0.00086	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALR—prostate cancer	2.51e-05	0.000857	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPAR1—prostate cancer	2.47e-05	0.000846	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRP—prostate cancer	2.47e-05	0.000846	CbGpPWpGaD
Equilin—HSD17B1—Disease—PARP1—prostate cancer	2.46e-05	0.000842	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR4—prostate cancer	2.46e-05	0.000842	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLCB2—prostate cancer	2.45e-05	0.000837	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LRP2—prostate cancer	2.45e-05	0.000837	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HPGDS—prostate cancer	2.44e-05	0.000835	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALCA—prostate cancer	2.43e-05	0.000832	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2C19—prostate cancer	2.43e-05	0.00083	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CX3CL1—prostate cancer	2.4e-05	0.000821	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—P4HB—prostate cancer	2.4e-05	0.000821	CbGpPWpGaD
Equilin—Estradiol—CYP3A5—prostate cancer	2.4e-05	0.0161	CrCbGaD
Equilin—HSD17B1—Metabolism—GSTT1—prostate cancer	2.37e-05	0.00081	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACHE—prostate cancer	2.37e-05	0.00081	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIST1H2BG—prostate cancer	2.36e-05	0.000806	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2A6—prostate cancer	2.34e-05	0.0008	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRB7—prostate cancer	2.34e-05	0.000799	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDE4D—prostate cancer	2.34e-05	0.000799	CbGpPWpGaD
Equilin—HSD17B1—Disease—HSPA1A—prostate cancer	2.33e-05	0.000798	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.33e-05	0.000797	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C3—prostate cancer	2.28e-05	0.000779	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIST1H4H—prostate cancer	2.28e-05	0.000778	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PRKACB—prostate cancer	2.26e-05	0.000775	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP17A1—prostate cancer	2.24e-05	0.000767	CbGpPWpGaD
Equilin—HSD17B1—Disease—CASP9—prostate cancer	2.24e-05	0.000765	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNG5—prostate cancer	2.22e-05	0.00076	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.21e-05	0.000756	CbGpPWpGaD
Equilin—Estropipate—CYP3A4—prostate cancer	2.2e-05	0.0148	CrCbGaD
Equilin—Estrone—CYP2E1—prostate cancer	2.18e-05	0.0146	CrCbGaD
Equilin—HSD17B1—Disease—PRKCQ—prostate cancer	2.17e-05	0.000742	CbGpPWpGaD
Equilin—Estrone—CYP1A1—prostate cancer	2.15e-05	0.0144	CrCbGaD
Equilin—HSD17B1—Metabolism—NCOA2—prostate cancer	2.14e-05	0.00073	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF10—prostate cancer	2.06e-05	0.000705	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC5A5—prostate cancer	2.04e-05	0.000697	CbGpPWpGaD
Equilin—Estradiol—ESR1—prostate cancer	2.04e-05	0.0137	CrCbGaD
Equilin—HSD17B1—Metabolism—CYP2E1—prostate cancer	1.99e-05	0.000681	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NQO1—prostate cancer	1.97e-05	0.000673	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFBR2—prostate cancer	1.96e-05	0.00067	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TH—prostate cancer	1.94e-05	0.000663	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTHLH—prostate cancer	1.94e-05	0.000662	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFBR1—prostate cancer	1.94e-05	0.000662	CbGpPWpGaD
Equilin—HSD17B1—Disease—ITPR1—prostate cancer	1.93e-05	0.00066	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.93e-05	0.000659	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP3A4—prostate cancer	1.92e-05	0.000656	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.91e-05	0.000653	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C3—prostate cancer	1.9e-05	0.000651	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKACB—prostate cancer	1.89e-05	0.000648	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1B1—prostate cancer	1.89e-05	0.000645	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP3CA—prostate cancer	1.85e-05	0.000631	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—THBS1—prostate cancer	1.85e-05	0.000631	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GGT1—prostate cancer	1.83e-05	0.000625	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ANXA1—prostate cancer	1.82e-05	0.000622	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA1—prostate cancer	1.8e-05	0.000616	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCZ—prostate cancer	1.79e-05	0.000611	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP19A1—prostate cancer	1.77e-05	0.000607	CbGpPWpGaD
Equilin—HSD17B1—Disease—LPL—prostate cancer	1.77e-05	0.000605	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFRB—prostate cancer	1.75e-05	0.000599	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PARP1—prostate cancer	1.72e-05	0.00059	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR4—prostate cancer	1.72e-05	0.00059	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—RXRA—prostate cancer	1.71e-05	0.000585	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CALCA—prostate cancer	1.7e-05	0.000583	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERCC2—prostate cancer	1.69e-05	0.000579	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.67e-05	0.000569	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL12—prostate cancer	1.66e-05	0.000569	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB3—prostate cancer	1.66e-05	0.000566	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR2—prostate cancer	1.65e-05	0.000565	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—COMT—prostate cancer	1.65e-05	0.000564	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—prostate cancer	1.64e-05	0.000561	CbGpPWpGaD
Equilin—Estradiol—CYP2C19—prostate cancer	1.63e-05	0.011	CrCbGaD
Equilin—Estradiol—CYP1A1—prostate cancer	1.63e-05	0.0109	CrCbGaD
Equilin—HSD17B1—Metabolism—ITPR1—prostate cancer	1.62e-05	0.000552	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—prostate cancer	1.59e-05	0.000544	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.59e-05	0.000543	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—prostate cancer	1.59e-05	0.000543	CbGpPWpGaD
Equilin—Ethinyl Estradiol—CYP3A4—prostate cancer	1.57e-05	0.0106	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CASP9—prostate cancer	1.57e-05	0.000536	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TYMS—prostate cancer	1.53e-05	0.000522	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NGFR—prostate cancer	1.52e-05	0.000519	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCQ—prostate cancer	1.52e-05	0.000519	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIF1A—prostate cancer	1.52e-05	0.000519	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTM1—prostate cancer	1.51e-05	0.000516	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAP3K7—prostate cancer	1.5e-05	0.000513	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPL—prostate cancer	1.48e-05	0.000506	CbGpPWpGaD
Equilin—HSD17B1—Disease—CAV1—prostate cancer	1.47e-05	0.000502	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF10—prostate cancer	1.44e-05	0.000493	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1A1—prostate cancer	1.43e-05	0.000489	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB2—prostate cancer	1.43e-05	0.000488	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ERCC2—prostate cancer	1.42e-05	0.000485	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VAV3—prostate cancer	1.39e-05	0.000476	CbGpPWpGaD
Equilin—HSD17B1—Disease—BAD—prostate cancer	1.38e-05	0.000472	CbGpPWpGaD
Equilin—Conjugated Estrogens—CYP3A4—prostate cancer	1.37e-05	0.00923	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—TGFBR2—prostate cancer	1.37e-05	0.000469	CbGpPWpGaD
Equilin—Estrone—CYP3A4—prostate cancer	1.37e-05	0.00921	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—ITPR1—prostate cancer	1.35e-05	0.000462	CbGpPWpGaD
Equilin—HSD17B1—Disease—APC—prostate cancer	1.34e-05	0.000457	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—prostate cancer	1.33e-05	0.000456	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGF—prostate cancer	1.32e-05	0.000452	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS1—prostate cancer	1.32e-05	0.000452	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARA—prostate cancer	1.31e-05	0.000447	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1R—prostate cancer	1.29e-05	0.000442	CbGpPWpGaD
Equilin—HSD17B1—Disease—GSK3B—prostate cancer	1.28e-05	0.000439	CbGpPWpGaD
Equilin—HSD17B1—Disease—INS—prostate cancer	1.27e-05	0.000433	CbGpPWpGaD
Equilin—HSD17B1—Disease—CREBBP—prostate cancer	1.24e-05	0.000424	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPL—prostate cancer	1.24e-05	0.000423	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAV1—prostate cancer	1.23e-05	0.00042	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFRB—prostate cancer	1.23e-05	0.00042	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ITGB3—prostate cancer	1.2e-05	0.000409	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAP2K1—prostate cancer	1.18e-05	0.000405	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—prostate cancer	1.18e-05	0.000402	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.17e-05	0.000402	CbGpPWpGaD
Equilin—HSD17B1—Disease—SERPINE1—prostate cancer	1.16e-05	0.000398	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB3—prostate cancer	1.16e-05	0.000397	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR2—prostate cancer	1.16e-05	0.000396	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF2—prostate cancer	1.13e-05	0.000385	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—prostate cancer	1.12e-05	0.000383	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—prostate cancer	1.11e-05	0.00038	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—prostate cancer	1.11e-05	0.00038	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAK2—prostate cancer	1.08e-05	0.000369	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIF1A—prostate cancer	1.06e-05	0.000364	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—INS—prostate cancer	1.06e-05	0.000363	CbGpPWpGaD
Equilin—HSD17B1—Disease—MDM2—prostate cancer	1.05e-05	0.00036	CbGpPWpGaD
Equilin—Estradiol—CYP3A4—prostate cancer	1.04e-05	0.00698	CrCbGaD
Equilin—HSD17B1—Metabolism—CREBBP—prostate cancer	1.04e-05	0.000355	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—prostate cancer	1.04e-05	0.000355	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—prostate cancer	1.04e-05	0.000355	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CAV1—prostate cancer	1.03e-05	0.000352	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—prostate cancer	1.02e-05	0.00035	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KDR—prostate cancer	1.02e-05	0.000348	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—prostate cancer	1.02e-05	0.000347	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—prostate cancer	9.91e-06	0.000339	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—prostate cancer	9.85e-06	0.000337	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BAD—prostate cancer	9.67e-06	0.000331	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1B—prostate cancer	9.62e-06	0.000329	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APC—prostate cancer	9.37e-06	0.00032	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—prostate cancer	9.37e-06	0.00032	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—prostate cancer	9.3e-06	0.000318	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS1—prostate cancer	9.26e-06	0.000317	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGF—prostate cancer	9.26e-06	0.000317	CbGpPWpGaD
Equilin—HSD17B1—Disease—CTNNB1—prostate cancer	9.09e-06	0.000311	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GSK3B—prostate cancer	8.99e-06	0.000307	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1A—prostate cancer	8.88e-06	0.000304	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INS—prostate cancer	8.86e-06	0.000303	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—prostate cancer	8.85e-06	0.000303	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CREBBP—prostate cancer	8.68e-06	0.000297	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—prostate cancer	8.58e-06	0.000293	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—prostate cancer	8.57e-06	0.000293	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—prostate cancer	8.5e-06	0.000291	CbGpPWpGaD
Equilin—HSD17B1—Disease—EP300—prostate cancer	8.44e-06	0.000289	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAP2K1—prostate cancer	8.29e-06	0.000283	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—prostate cancer	8.23e-06	0.000282	CbGpPWpGaD
Equilin—HSD17B1—Disease—SRC—prostate cancer	8.21e-06	0.000281	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—prostate cancer	8.14e-06	0.000278	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—prostate cancer	7.92e-06	0.000271	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF2—prostate cancer	7.88e-06	0.00027	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—prostate cancer	7.77e-06	0.000266	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAK2—prostate cancer	7.56e-06	0.000258	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—prostate cancer	7.42e-06	0.000254	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDM2—prostate cancer	7.38e-06	0.000252	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—prostate cancer	7.36e-06	0.000252	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—prostate cancer	7.34e-06	0.000251	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—prostate cancer	7.27e-06	0.000249	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—prostate cancer	7.2e-06	0.000246	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—prostate cancer	7.18e-06	0.000245	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—EP300—prostate cancer	7.07e-06	0.000242	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—prostate cancer	6.9e-06	0.000236	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—prostate cancer	6.8e-06	0.000233	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1B—prostate cancer	6.73e-06	0.00023	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—prostate cancer	6.6e-06	0.000226	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—prostate cancer	6.59e-06	0.000225	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—prostate cancer	6.42e-06	0.00022	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CTNNB1—prostate cancer	6.36e-06	0.000218	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—prostate cancer	6.25e-06	0.000214	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—prostate cancer	6.24e-06	0.000213	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1A—prostate cancer	6.21e-06	0.000213	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—prostate cancer	6.2e-06	0.000212	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EP300—prostate cancer	5.91e-06	0.000202	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SRC—prostate cancer	5.75e-06	0.000197	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—prostate cancer	5.6e-06	0.000192	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—prostate cancer	5.55e-06	0.00019	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—prostate cancer	5.53e-06	0.000189	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—prostate cancer	5.23e-06	0.000179	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—prostate cancer	5.15e-06	0.000176	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—prostate cancer	5.14e-06	0.000176	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—prostate cancer	5.1e-06	0.000175	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—prostate cancer	5.04e-06	0.000172	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—prostate cancer	4.76e-06	0.000163	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—prostate cancer	4.37e-06	0.00015	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—prostate cancer	4.27e-06	0.000146	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—prostate cancer	4.23e-06	0.000145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—prostate cancer	3.87e-06	0.000132	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—prostate cancer	3.57e-06	0.000122	CbGpPWpGaD
